Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06343350Completed

OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection

Role: collaborator

NCT01792882Withdrawn

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

Role: lead

NCT02239575Withdrawn

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples

Role: lead

NCT04450108Not ApplicableCompleted

Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients

Role: collaborator

NCT01922024Completed

Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis Unyvero LRT55 Application

Role: collaborator

All 5 trials loaded